ReviewPharmaceuticals (Basel, Switzerland)2022

Chalcones as Potential Ligands for the Treatment of Parkinson's Disease.

Ewelina Królicka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.